SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-20-023605
Filing Date
2020-11-12
Accepted
2020-11-12 16:00:41
Documents
61
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q mbrx20200930_10q.htm   iXBRL 10-Q 1168053
2 EXHIBIT 10.2 ex_213646.htm EX-10.2 266095
3 EXHIBIT 10.3 ex_213647.htm EX-10.3 87776
4 EXHIBIT 31.1 ex_202517.htm EX-31.1 13435
5 EXHIBIT 31.2 ex_204532.htm EX-31.2 13268
6 EXHIBIT 32.1 ex_204533.htm EX-32.1 6602
7 EXHIBIT 32.2 ex_204534.htm EX-32.2 6678
13 logo.jpg GRAPHIC 7817
  Complete submission text file 0001437749-20-023605.txt   6294100

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA mbrx-20200930.xsd EX-101.SCH 54164
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mbrx-20200930_cal.xml EX-101.CAL 38007
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mbrx-20200930_def.xml EX-101.DEF 339200
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE mbrx-20200930_lab.xml EX-101.LAB 332334
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mbrx-20200930_pre.xml EX-101.PRE 367385
14 EXTRACTED XBRL INSTANCE DOCUMENT mbrx20200930_10q_htm.xml XML 1062842
Mailing Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007
Business Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007 713-300-5160
Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings)

IRS No.: 474671999 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37758 | Film No.: 201306468
SIC: 2834 Pharmaceutical Preparations